Related Experiment Video
Updated: Aug 8, 2026
05:05
Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
Mediation of the ocular response to cyclocryocoagulation
Summary
Cyclocryocoagulation disrupts the rabbit eye's blood-aqueous barrier via prostaglandins and neural pathways. Inhibiting prostaglandins and using anesthesia reduced ocular response, indicating a dual mediation mechanism.
Area of Science:
- Ophthalmology
- Neuroscience
- Pharmacology
Background:
- Cyclocryocoagulation is a procedure that can disrupt the blood-aqueous barrier.
- The roles of prostaglandins and neural pathways in this disruption are not fully understood.
Purpose of the Study:
- To investigate the involvement of prostaglandins and neural pathways in the disruption of the blood-aqueous barrier after cyclocryocoagulation in rabbit eyes.
Main Methods:
- Intravenous administration of acetylsalicylic acid (a prostaglandin inhibitor) preoperatively.
- Application of retrobulbar and topical anesthesia.
- Measurement of intraocular pressure (IOP) and aqueous humor protein concentration.
Main Results:
- Both acetylsalicylic acid and ocular anesthesia reduced IOP and aqueous humor protein levels.
- Combined administration of acetylsalicylic acid and anesthesia further reduced postoperative reactions but did not completely abolish the ocular response.
- The blood-aqueous barrier breakdown allows leakage of proteins of various molecular weights in equal ratios.
Conclusions:
- The acute ocular response to cyclocryocoagulation is mediated by both prostaglandins and a neural component.
- This dual mediation is attributed to the combined thermal and mechanical injury affecting prostaglandin synthesis and trigeminal nerve innervation.
- Further research may explore combined therapeutic strategies targeting both pathways.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...